Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS

NCT02048969 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No subjects were able to be recruited for the study.

Conditions

Hepatic Encephalopathy
Liver Cirrhosis

Interventions

DRUG: Flumazenil
DRUG: Placebo

Sponsor

Yale University

Collaborators

[object Object]